Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms, Nerve Tissue 1Neoplasms 1Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Radiotherapy 8Temozolomide 7Lomustine 6Procarbazine 4Carmustine 4Bevacizumab 4Vincristine 3Surgical Procedures, Operative 2Administration, Oral 2vorasidenib 1fluorodopa F 18 1contrast agent BR1 1carmustine, poliferprosan 20 drug combination 1Valproic Acid 1Tranexamic Acid 1Trabedersen 1TIC10 compound 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Microbubbles 1Methylphenidate 1Methods 1Isotretinoin 1Infusions, Intravenous 1IL13-PE38 1Fentanyl 1Eflornithine 1Drug Delivery Systems 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Glioma × Microbubbles × Clear all
NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NaviFUS Corporation

Phase 3 Recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡